MarketInOut Stock Screener Log In | Sign Up

King International Investment Ltd

HKSE • Healthcare • Diagnostics & Research • Quote as of 10/28/2026 10:21
King International Investment Ltd stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeHKSE
Market Capitalization275.68 mln
Float136 mln
Earnings Date11/27/2026

EPS

0.01
Overpriced

P / E

83.00
Speculative

Piotroski F-Score

5 / 9
Neutral

Relative Strength

1 / 100
Severely lagging

Debt / Equity

0.33
Low leverage

Pre-Tax Margin

5%
Low margin

Business Description

Founded in 2001 and headquartered in Central Hong Kong, King International Investment Limited operates across two main areas: a healthcare division offering genetic testing, health data analysis, and corporate health services across China and Hong Kong, and a money lending division providing financing activities. The company was previously called Life Healthcare Group Limited before adopting its current name in December 2023.

Key Fundamentals

EPS0.01
P/E83.00
ROE0.80
RPS0.77
ROIC0.82
ROA0.54
Interest Cover3.00
EBITDA, mln10.43
EV / EBITDA30.54
EV / EBIT32.31
Revenue, mln143
EV / Revenue2.22

Quote Details

Last 0.83
Change 0.05 (6.41%)
Open 0.77
Volume 65,000
Turnover 53,950
Average Volume 549,224

Financial Ratios

Pre-Tax Profit Margin5
Leverage Ratio1.62
Current Ratio2.64
Price / Book1.00
Price / Tangible Book1.00
Debt / Equity0.33
Price / Sales1.69

Financial Strength

Altman Z-Score-2.71
Piotroski F-Score 5 / 9
Price to Intrinsic Value3.25
Price to Graham Number2.60

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 16.9% 98 / 100   
1 Month -44.3% 2 / 100   
2 Months 31.75% 93 / 100   
6 Months 7.79% 82 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog